RxDoctor Payments Data

Iulia Oneill, MD

Family Medicine · Bloomingdale, ILNPI 1255381927

Payments from drug & device makers

$1,685in general payments, 2019–2025

Across 86 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$343
  • AstraZeneca$275
  • Novo Nordisk$229
  • Amgen$147
  • Boehringer Ingelheim$138
  • GSK$105
  • plus $448 from 10 others

What the payments were for

  • Food & beverage$1,679100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,685 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$116,408
Medicare patients
198
Services billed
1,465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$64,993
MounjaroTirzepatide37$58,461
JardianceEmpagliflozin20$30,348
EliquisApixaban25$23,361
FarxigaDapagliflozin Propanediol17$14,297
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$13,875
JanuviaSitagliptin Phosphate16$12,661
BrilintaTicagrelor11$6,075
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$4,022
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$3,905
Rosuvastatin Calcium378$3,633
Pantoprazole Sodium215$2,777
Levothyroxine Sodium297$2,752
Fluticasone Propionate161$2,685
Atorvastatin Calcium314$2,361

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$229$64,99349 claims
Lilly USA, LLCMounjaro$104$58,46137 claims
Boehringer IngelheimJardiance$138$30,34820 claims
PfizerEliquis, Paxlovid$98$24,81641 claims
AstraZenecaFarxiga, Brilinta$275$20,37128 claims
MerckJanuvia$12$12,66116 claims
AbbVieSynthroid$343$2,31122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Bloomingdale

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →